Articles
Key challenges within rare disease clinical trials

Key challenges within rare disease clinical trials

Yaffa Rubinstein shares the goals of the Office of Rare Diseases Research and explains some of the key challenges the rare disease patient community faces when it comes to recruiting for clinical trials. One of the biggest challenges in clinical trials is patient recruitment for rare diseases. But with the rise in public awareness...

Articles
Open access innovating in clinical trial reporting

Open access innovating in clinical trial reporting

Angela Wipperman, Helene Faure and Iain Hrynaszkiewicz share their opinions on open access innovation when reporting about clinical trials. Online, open access medical publishing has provided new opportunities for increased transparency and innovation in clinical trial reporting...

Articles
Should pharma continue to invest in disease state education websites?

Should pharma continue to invest in disease state education ...

Richard Meyer explains why it is time we started looking at pharmaceutical marketing through the eyes of the consumer. One of the greatest strengths any marketer can demonstrate is the ability to look at their marketing as a consumer not a DTC marketer...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more